{"schema":"hottub-news/story/v1","story":"st_jff5q3bgcx6g2yj3qe6q","title":"North America Clinical Trials Market Report 2026-2034: Size, Share, Trends, and Forecast by Phase, Indication, Study Design, Country, and Company | AI Adoption Fuels 6% CAGR","title_en":null,"outlets":1,"brief":null,"page":"https://hottub.news/stories/north-america-clinical-trials-market-report-2026-2034-size-share-trends-jff5q3bgcx","count":1,"items":[{"id":"n_jff5q3bgcx6g2yj3qe6q","seq":859346,"kind":"press_release","title":"North America Clinical Trials Market Report 2026-2034: Size, Share, Trends, and Forecast by Phase, Indication, Study Design, Country, and Company | AI Adoption Fuels 6% CAGR","url":"https://www.globenewswire.com/news-release/2026/09/30/3371610/28124/en/north-america-clinical-trials-market-report-2026-2034-size-share-trends-and-forecast-by-phase-indication-study-design-country-and-company-ai-adoption-fuels-6-cagr.html","summary":"AI, decentralized trials and remote monitoring improve recruitment, data quality and speed, while oncology investment, partnerships and Mexico’s cost advantages enhance ROI AI, decentralized trials and remote monitoring improve recruitment, data quality and speed, while oncology investment, partnerships and Mexico’s cost advantages enhance ROI","published":"2026-09-30T08:39:00Z","seen":"2026-09-30T08:40:22Z","lang":"en","source":{"id":"globenewswire-all","name":"GlobeNewswire — all","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-all","topics":["business"],"entities":[{"id":"Q49","name":"North America","type":"place"},{"id":"Q11660","name":"artificial intelligence","type":"other"}],"story":"st_jff5q3bgcx6g2yj3qe6q","category":"economy-business","category_p":0.4300000071525574,"sentiment":"neutral","tone":0.3199999928474426,"political":0.03999999910593033}]}